What Hospitals Should Know About the Smiths Medical Implantable Port Recall

Overview of the Recall

On March 19, 2025, Smiths Medical issued a recall for its ProPort Plastic Implantable Ports due to a manufacturing error that may cause separation of the port body, potentially leading to serious patient complications. These implantable ports are commonly used for long-term intravenous treatments, such as chemotherapy and parenteral nutrition, making this recall particularly critical for hospitals and healthcare providers.

Key Risks & Patient Safety Concerns

Hospitals using Smiths Medical implantable ports should be aware of the following risks:

• Device Separation: The recalled ports have a risk of detaching, leading to catheter migration and potential embolization.

• Increased Risk of Infection: A compromised port can lead to bloodstream infections and sepsis.

• Potential for Additional Procedures: Patients with the affected devices may require removal and replacement, increasing surgical risks and recovery time.

Steps Hospitals Should Take

1. Identify Affected Devices

• Review your inventory and patient records to determine if the recalled Smiths Medical ProPort ports have been used.

• Use the FDA recall notice or manufacturer’s guidelines to match lot numbers with affected devices.

2. Notify Relevant Departments & Staff

• Alert oncology units, infusion centers, and surgical teams who regularly use implantable ports.

• Ensure nursing and pharmacy teams are informed to monitor patients with existing implants.

3. Communicate With Patients

• Proactively reach out to patients with affected implants to schedule evaluations.

• Educate patients on potential symptoms of port failure, such as swelling, pain, or difficulty with infusions.

4. Identify Alternative Implantable Port Solutions

Given the recall, hospitals must source alternative implantable ports that meet safety and regulatory requirements. Consider the following when choosing replacement options:

• FDA-approved implantable ports from other manufacturers

• Safety track record and clinical trial data

• Ease of insertion and maintenance

5. Report Adverse Events

If any complications arise from a recalled device, hospitals should report cases to the FDA’s MedWatch program and coordinate with Smiths Medical for recall compliance.

How SLIMedical.com Can Help

SLIMedical.com works with hospitals and healthcare facilities to ensure they have safe and reliable alternatives to recalled medical devices. If your facility requires guidance on alternative implantable ports or bulk procurement solutions, contact us today for assistance.

Final Recommendations

• Check inventory immediately and remove affected devices.

• Monitor patients with implanted ports and be prepared for necessary replacements.

• Source alternative implantable ports to maintain continuity of care.

• Train staff on safety measures related to recalled devices.

Staying ahead of recalls and proactively addressing patient safety concerns is critical for hospital compliance and quality of care. For more updates on medical device recalls and procurement strategies, visit SLIMedical.com.